Latest Market News

Deep Yellow Limited has accelerated development at its flagship Tumas uranium project in Namibia, nearing construction readiness with significant engineering and earthworks milestones. Exploration success at the nearby Tinkas Prospect and strategic leadership appointments position the company well amid a strengthening uranium market.

EVE Health Group has appointed Ben Rohr as CEO, shifting Damian Wood to focus on regulatory and clinical affairs, aiming to sharpen commercial execution amid ongoing product rollouts.

Lindian Resources has locked in a stable, low-cost sulphuric acid supply for its Kazakhstan processing plant, insulating its downstream rare earths strategy from China's looming export ban and volatile global markets.

Sabre Resources (ASX:SBR) is set to expand its footprint in the Northern Territory through an 80% acquisition of major gold and copper-gold projects, including drill-ready targets on extensions of the Tennant Creek Mineral Field. Drilling is scheduled to begin shortly after shareholder approval.

ECS Botanics reports a third straight quarter of positive operating cash flow, driven by strong B2C growth and strategic international shipments to Germany and New Zealand.

Barramundi Limited’s portfolio took a heavy hit in Q1 2026, with a 15.4% adjusted NAV decline amid AI disruption anxieties and geopolitical tensions. The fund responded by trimming tech holdings and adding miners BHP and Rio Tinto, betting on copper demand and scale advantages.

Kingfish Limited’s portfolio endured a tough first quarter of 2026, with a 7.2% adjusted NAV decline amid Iran conflict-driven volatility. While a2 Milk’s expansion in China buoyed gains, shares in consumer-exposed names and tech-linked Vista Group plunged sharply.

TruScreen Group has met its FY2026 revenue guidance with a 41% jump in product sales, while investing heavily in new markets and pursuing a major UNITAID funding bid that could reshape its medium-term outlook.

MFF Capital Investments has updated its dividend distribution details for the half-year ending December 2025, confirming a fully franked 10-cent dividend payable in May and setting reinvestment plan prices at AUD 4.577.

Icetana AI reported a 51% year-on-year jump in annual recurring revenue to $2.6 million but faced a $1.2 million net operating cash outflow in Q3 FY26, prompting plans for a capital raise amid expected cash flow improvements.

Castile Resources has kicked off pilot plant bench scale testing for its Rover 1 project, integrating a 41% resource upgrade and higher metal prices into its Bankable Feasibility Study. The company also secured $8.4 million in funding and is preparing for exploration drilling amid regional consolidation.

Bio-Gene Technology is progressing critical toxicology studies for Flavocide with a targeted APVMA submission in March 2027, while forging a strategic partnership to launch Qcide insecticides in Japan by late 2026.